TrialJAMA ophthalmology2017

Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.

David W Hutton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.